The global prefilled syringes market is growing at a significant rate, due to the mounting demand for biologics and biosimilars and emergent injectable drugs pipeline.

The market has witnessed a high demand for conventional syringes over the last few years due to increasing adoption of self-administered injectable drug.

Request for sample copy of this research report at https://www.vynzresearch.com/healthcare/prefilled-syringes-market/request-sample

The rapid increase in aging population, growing demand for vaccine, increasing prevalence of chronic diseases, increasing healthcare expenditure, growth in disposable income, and increasing usage of home-use devices are the primary growth drivers for prefilled syringes market.

Increasing demand for self-injection device is also facilitating the growth for the prefilled syringes market. Moreover, the risk of needle stick injury is reduced in many syringes, due to retractable needles and lack of needles in many systems. In addition, a self-injection device provides more accurate dosage volume, which further reduces the wastage of drugs.
Europe is the largest prefilled syringe market as in the region the prevalence of the chronic disease is increasing.

Asia-Pacific is observed to witness the fastest growth in the market, as the region comprises of the growing demand for vaccine for the management of chronic diseases and mounting use of biologics and biosimilars.

Read Full Research Report Description at https://www.vynzresearch.com/healthcare/prefilled-syringes-market

Key players in the prefilled syringes industry are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe.

Becton, Dickinson and Company, Weigao Group, Gerresheimer AG, SCHOTT AG, Catalent, Inc., West Pharmaceutical Services, Inc., Ompi, Vetter Pharma International GmbH, Nipro Corporation, and MedPro Inc. are the key players offering prefilled syringes.

Source: VynZ Research